Target intelligence / Profile preview

RNA, U2 small nuclear 3, pseudogene (RNU2-3P)

Target
RNU2-3P
Molecular classification
Other (Pseudogene)
01

Overview

The RNU2-3P gene (RNA, U2 small nuclear 3, pseudogene) is a human pseudogene related to the U2 small nuclear RNA family. Unlike the functional U2 snRNA, which is a core component of the spliceosome and essential for intron removal in pre-mRNA splicing[1], RNU2-3P does not encode a functional product and has no recognized biological activity. It is annotated as a pseudogene in genomic databases and is not known to contribute to disease, interact with drugs, or act as a biomarker. Alternative names include U2, RNU2P1, and RNA, U2 small nuclear pseudogene 1[5][2][3]. No evidence supports its use as a therapeutic target or its involvement in any biological or disease processes. It is important to distinguish RNU2-3P—a non-functional pseudogene—from functional U2 snRNA, which does play critical biological roles[1][5][2].

Other names
U2RNU2P1U2, RNA, U2 small nuclear pseudogene 1RNU2-3P
02

Biological functions

Other (No known biological function as this locus is a pseudogene[5][2][3])
03

Disease associations

Other (No known involvement in any disease as this locus is a pseudogene[5][2][3])

Beyond the preview

Go deeper on RNA, U2 small nuclear 3, pseudogene (RNU2-3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 3, pseudogene (RNU2-3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call